Literature DB >> 22956305

Association of bone mineral density with incidental renal stone in long-term survivors of childhood acute lymphoblastic leukemia.

Prasad L Gawade1, Kirsten K Ness, Shelly Sharma, Zhenghong Li, Deo Kumar Srivastava, Sheri L Spunt, Kerri Nottage, Matthew J Krasin, Melissa M Hudson, Sue C Kaste.   

Abstract

PURPOSE: Our objective was to evaluate the association between low bone mineral density (BMD) and incidental renal stones among long-term survivors of childhood acute lymphoblastic leukemia (ALL).
METHODS: Adult participants who were 10+ years from their childhood ALL diagnosis and members of the St. Jude Lifetime Cohort study were recruited between December 2007 and March 2011. During their risk-based medical evaluations, they underwent quantitative computed tomography (QCT) to evaluate BMD. Incidental renal stones were identified by radiologists' review of axial QCT source images. Demographic and dietary information were abstracted from health surveys and the Block Food Frequency questionnaire, respectively. The multivariable logistic regression model was used for analysis.
RESULTS: At a median of 26.1 years from diagnosis, BMD Z scores were ≤-2 in 34 of 662 (5.2 %) and renal stones detected in 73 of 662 (11 %) participants. Adjusted for age, renal radiation, dietary vitamin D, gender, and body mass index, when compared to those with BMD Z scores ≥0, the risk of renal stones was increased among those with BMD Z scores ≤-2 (odds ratio [OR], 2.92; 95 % confidence interval [CI] 1.14-7.48). Risk of renal stones significantly increased for older age (45-54 vs.18-24 years; OR, 3.70; 95 % CI 1.11-12.35) whereas the risk was higher but nonsignificant for >141.5 IU (sample median) daily intake of vitamin D (OR, 1.64; 95 % CI 0.98-2.75). CONCLUSIONS AND IMPLICATIONS FOR CANCER SURVIVORS: Older ALL survivors with BMD Z scores ≤-2 are at risk for renal stones and should be counseled so that appropriate follow-up care can be provided for those among whom renal stones are detected.

Entities:  

Mesh:

Year:  2012        PMID: 22956305      PMCID: PMC3529472          DOI: 10.1007/s11764-012-0241-y

Source DB:  PubMed          Journal:  J Cancer Surviv        ISSN: 1932-2259            Impact factor:   4.442


  34 in total

1.  Effective dose values in bone mineral measurements by photon absorptiometry and computed tomography.

Authors:  W A Kalender
Journal:  Osteoporos Int       Date:  1992-03       Impact factor: 4.507

2.  Determinants of osteopenia in male renal-stone-disease patients with idiopathic hypercalciuria.

Authors:  Emmanuel Letavernier; Olivier Traxer; Michel Daudon; Mohammed Tligui; Jérôme Hubert-Brierre; Dominique Guerrot; Aline Sebag; Laurent Baud; Jean-Philippe Haymann
Journal:  Clin J Am Soc Nephrol       Date:  2011-03-24       Impact factor: 8.237

Review 3.  Quantitative CT for determination of bone mineral density: a review.

Authors:  C E Cann
Journal:  Radiology       Date:  1988-02       Impact factor: 11.105

4.  Kidney stones: a global picture of prevalence, incidence, and associated risk factors.

Authors:  Victoriano Romero; Haluk Akpinar; Dean G Assimos
Journal:  Rev Urol       Date:  2010

5.  Comparison of two diets for the prevention of recurrent stones in idiopathic hypercalciuria.

Authors:  Loris Borghi; Tania Schianchi; Tiziana Meschi; Angela Guerra; Franca Allegri; Umberto Maggiore; Almerico Novarini
Journal:  N Engl J Med       Date:  2002-01-10       Impact factor: 91.245

6.  Bone mineral decrements in survivors of childhood acute lymphoblastic leukemia: frequency of occurrence and risk factors for their development.

Authors:  S C Kaste; D Jones-Wallace; S R Rose; J M Boyett; R H Lustig; G K Rivera; C H Pui; M M Hudson
Journal:  Leukemia       Date:  2001-05       Impact factor: 11.528

7.  Analysis of bone mineral density in urolithiasis patients.

Authors:  Hidenori Tsuji; Tohru Umekawa; Takashi Kurita; Hirotsugu Uemura; Masanori Iguchi; Kokai Kin; Kazuhiro Kushida
Journal:  Int J Urol       Date:  2005-04       Impact factor: 3.369

8.  Urolithiasis in pediatric patients with acute lymphoblastic leukemia.

Authors:  S C Howard; S D Kaplan; B I Razzouk; G K Rivera; J T Sandlund; R C Ribeiro; J E Rubnitz; A J Gajjar; W Ke; M L Hancock; J P Skoch; S Roy; M Hudson; C-H Pui
Journal:  Leukemia       Date:  2003-03       Impact factor: 11.528

9.  Methotrexate-induced renal impairment: clinical studies and rescue from systemic toxicity with high-dose leucovorin and thymidine.

Authors:  H T Abelson; M T Fosburg; G P Beardsley; A M Goorin; C Gorka; M Link; D Link
Journal:  J Clin Oncol       Date:  1983-03       Impact factor: 44.544

Review 10.  Bone mineral density deficits in survivors of childhood cancer: long-term follow-up guidelines and review of the literature.

Authors:  Karen Wasilewski-Masker; Sue C Kaste; Melissa M Hudson; Natia Esiashvili; Leonard A Mattano; Lillian R Meacham
Journal:  Pediatrics       Date:  2008-03       Impact factor: 7.124

View more
  2 in total

Review 1.  Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group.

Authors:  Jenneke E van Atteveld; Renée L Mulder; Marry M van den Heuvel-Eibrink; Melissa M Hudson; Leontien C M Kremer; Roderick Skinner; W Hamish Wallace; Louis S Constine; Claire E Higham; Sue C Kaste; Riitta Niinimäki; Sogol Mostoufi-Moab; Nathalie Alos; Danilo Fintini; Kimberly J Templeton; Leanne M Ward; Eva Frey; Roberto Franceschi; Vesna Pavasovic; Seth E Karol; Nadia L Amin; Lynda M Vrooman; Arja Harila-Saari; Charlotte Demoor-Goldschmidt; Robert D Murray; Edit Bardi; Maarten H Lequin; Maria Felicia Faienza; Olga Zaikova; Claire Berger; Stefano Mora; Kirsten K Ness; Sebastian J C M M Neggers; Saskia M F Pluijm; Jill H Simmons; Natascia Di Iorgi
Journal:  Lancet Diabetes Endocrinol       Date:  2021-07-30       Impact factor: 44.867

Review 2.  Induced urinary crystal formation as an analytical strategy for the prediction and monitoring of urolithiasis and other metabolism-related disorders.

Authors:  Norbert Laube; Wolfgang Berg; Falk Bernsmann; Sascha Gravius; Florian Klein; Stefan Latz; Dirk von Mallek; Tadeusz Porowski; Thomas Randau; Anna Wasilewska; Christian Fisang
Journal:  EPMA J       Date:  2014-08-16       Impact factor: 6.543

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.